<!DOCTYPE html>
<html>
<head>
    <title>BREAKING: Federal Register: Teva Branded Pharmaceutical Products R&D, Inc., et al.; Withdrawal of Approval of 39 New Drug Applications; Correction</title>
    <meta charset="UTF-8">
    <style>
        body { font-family: Georgia, serif; max-width: 800px; margin: 0 auto; padding: 20px; }
        h1 { border-bottom: 2px solid #333; }
        .breaking { background: #fff3cd; border-left: 4px solid #dc3545; padding: 15px; }
        .source { background: #f8f9fa; padding: 10px; margin-top: 20px; font-size: 0.9em; }
        .timestamp { color: #666; }
    </style>
</head>
<body>
    <h1>BREAKING: Federal Register: Teva Branded Pharmaceutical Products R&D, Inc., et al.; Withdrawal of Approval of 39 New Drug Applications; Correction</h1>
    <p class="timestamp">Published: 2025-10-03 | Source: Federal Register</p>
    <div class="breaking">
        <p><strong>The Food and Drug Administration (FDA) is correcting a notice that appeared in the Federal Register on August 4, 2025 (90 FR 36440). The document announced the withdrawal of approval of 39 new drug applications (NDA) from multiple applicants, withdrawn as of September 3, 2025. The document erroneously included NDA number 021290. The correct NDA number is 020212 for Zinecard (dexrazoxane hydrochloric acid (HCl)) Injectable, equivalent to (EQ) 250 milligrams (mg) base/ vial and EQ 500 mg base/vial...</strong></p>
    </div>
    <h2>Document Details</h2>
    <p><strong>Document Type:</strong> Notice</p>
    <p><strong>Agency:</strong> Health and Human Services Department, Food and Drug Administration</p>
    <p><strong>Document Number:</strong> 2025-19440</p>
    <p><strong>Publication Date:</strong> 2025-10-03</p>
    <h2>Official Source</h2>
    <p>Read the full document at: <a href="https://www.federalregister.gov/documents/2025/10/03/2025-19440/teva-branded-pharmaceutical-products-randd-inc-et-al-withdrawal-of-approval-of-39-new-drug">https://www.federalregister.gov/documents/2025/10/03/2025-19440/teva-branded-pharmaceutical-products-randd-inc-et-al-withdrawal-of-approval-of-39-new-drug</a></p>
    <div class="source"><strong>Source:</strong> Federal Register - 2025-19440</div>
    <p><a href="index.html">Back to Breaking News Wire</a></p>
</body>
</html>
